RecruitingNCT05412810

Oxidative Lipidomic Biomarkers During Mechanical Ventilation in Critically Ill Patients (OXY-BAL).


Sponsor

Ohio State University

Enrollment

200 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to identify and determine the levels of oxidized lipids and lipid mediators following exposure to oxygen supplementation during mechanical ventilation by oxidative lipidomics. The investigators will include patients with mechanical ventilation and have received FiO2=\>0.5 atleast 90 minutes and collected two sequential mini bronchoalveolar lavage on them 24 hours apart. Mass Spectrometry Lipid chromatography will be conducted and clinical data will be analyzed.


Eligibility

Min Age: 18 YearsMax Age: 110 Years

Inclusion Criteria1

  • Adults age => 18 and needing Mechanical ventilation in Intensive Care unit expected atleast for 48 hours

Exclusion Criteria5

  • Mechanical ventilation, only needed for performing procedures- bronchoscopy, esophagogastroduodenoscopy, colonoscopy, or others
  • Chronic respiratory failure prior to admission;
  • Hemoptysis or diffuse alveolar hemorrhage
  • Medication use such as N acetyl cysteine; aspirin, fish oil supplements.
  • Primary team prohibits bronchoscopy for a specific clinical indication or safety;

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERoxygen

oxygen exposure of more than 50% for 1.5 hours


Locations(1)

Ohio State University Medical Center

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05412810


Related Trials